Pediatrics | European Cystic Fibrosis Society (ECFS)

Tracking the journey of elexacaftor-tezacaftor-ivacaftor in the bodies of children with cystic fibrosis

The Presence of Clostridioides difficile in Stool Samples of Children with Cystic Fibrosis

Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis

Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index

Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index

An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).

The use of antimicrobial susceptibility testing in pediatric cystic fibrosis pulmonary exacerbations

Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10years old.

Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children.

Objective airway artery dimensions compared to CT scoring methods assessing structural cystic fibrosis lung disease